Centre Hospitalier Universitaire Brugmann

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Duchenne muscular dystrophy1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Heart failure1 trial
• Hodgkin lymphoma1 trial
• Obesity1 trial
• Peripheral artery disease1 trial
• Stroke1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Recruiting2 trials

Lead sponsor

• Eli Lilly and Company2 trials
• European Organisation for Research and Treatment of Cancer - EORTC1 trial
• Genethon1 trial

Running trials

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Luc Lasser (principal investigator)

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Natural History of Duchenne Muscular Dystrophy

  NCT03882827· Genethon· Source

  Contact: Francesco MUNTONI, Pr

• Active, not recruiting

  Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

  NCT00005584· Phase 3· European Organisation for Research and Treatment of Cancer - EORTC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Duchenne muscular dystrophy1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting